Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bioharvest Sciences Inc BHST


Primary Symbol: C.BHSC

Consumer Defensive Household & Personal Products Biotechnology
BioHarvest Sciences Inc. is a Canada-based biotechnology company. The Company offers Botanical Synthesis, its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The Company is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business... see more

Recent & Breaking News (CSE:BHSC)

BioHarvest Sciences Reports First Quarter 2024 Financial Results

Newsfile May 30, 2024

BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 P.M. Eastern Time

Newsfile May 1, 2024

BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results

Newsfile April 30, 2024

BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity

Newsfile April 16, 2024

BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables

Newsfile March 21, 2024

BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024

Newsfile March 14, 2024

BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit

Newsfile March 13, 2024

BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on March 12-13, 2024

Newsfile March 7, 2024

BioHarvest Sciences to Host Corporate Update Discussing Launch of CDMO Business Unit on March 13 at 2:30 p.m. Eastern Time

Newsfile February 29, 2024

BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via Its Newly Launched Botanical Synthesis CDMO Business Unit

Newsfile February 26, 2024

BioHarvest Sciences Issues Clarification to February 15, 2024 News Release Announcing Engagement with IR Firm

Newsfile February 20, 2024

BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

Newsfile February 15, 2024

BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference

Newsfile February 12, 2024

BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update

Newsfile January 8, 2024

BioHarvest Sciences Inc. Closes Final Tranche of Oversubscribed $13.5M Private Placement

Newsfile December 27, 2023

BioHarvest Sciences Announces Major Product Launch of VINIA-Based Functional Coffees

Newsfile December 13, 2023

BioHarvest Sciences to Host Virtual Shareholder Update December 13, 2023, 2:30pm ET

Newsfile December 1, 2023

BioHarvest Sciences Reports Q3 2023 Revenue Demonstrating Continued Growth Momentum

Newsfile November 29, 2023

BioHarvest Sciences Inc. Announces $11.78M Raised in First Tranche of $13.5M Private Placement

Newsfile October 30, 2023

Health Canada Grants BioHarvest Sciences License for VINIA Sales in Canada

Newsfile October 10, 2023